Source: Health Canada shortage reports · Updated Jul 29, 2026
Rasagiline is in a widespread shortage in Canada. 4 of 7 reported products are affected. The latest manufacturer estimate for full recovery is Sep 4, 2026.
A Parkinson's disease medication used to help control movement symptoms such as tremor and stiffness.
Products affected
4 / 7
In shortage since
Oct 8, 2025
Est. full return
Sep 4, 2026
Reports on file
35
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP RASAGILINE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491982 · since Apr 21, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · since Mar 12, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-RASAGILINE
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02418436 · since Jan 21, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP RASAGILINE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491982 · since Oct 31, 2025, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-RASAGILINE
1MG · TABLET · APOTEX INC
DIN 02404699 · since Oct 8, 2025, est. end Apr 17, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491982 · ended Jan 23, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · ended Jan 23, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-RASAGILINE
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02418436 · ended Jan 7, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-RASAGILINE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02418444 · ended Sep 23, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · ended Jul 15, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
reversed
TEVA-RASAGILINE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02418444
Showing 12 of 35 reports. All reports are on file with Health Canada.
What's happening
Rasagiline is currently affected by 4 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Rasagiline is classified under “DOPAMINERGIC AGENTS” (ATC N04BD).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jul 31, 2026 → Sep 4, 2026
Jul 29, 2026
Estimated end date pushed back : Jul 31, 2026 → Sep 4, 2026
Common questions
What is Rasagiline used for?
A Parkinson's disease medication used to help control movement symptoms such as tremor and stiffness.
When will Rasagiline be back in stock in Canada?
The latest manufacturer estimate is Sep 4, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Rasagiline in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.